Omega Therapeutics IPO

Omega Therapeutics is a biotech company leveraging epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines. The company uses highly selective and direct control of the human genome to treat and cure disease.

Register for Details

For more details on financing and valuation for Omega Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Omega Therapeutics's ticker symbol?


What is Omega Therapeutics's stock price?

6.64 as of 3/28/23

Learn more about Omega Therapeutics

Forge green plus iconForge green minus icon

When was Omega Therapeutics founded?

Omega Therapeutics was founded in 2016.